Business Wire

YuppTV to Exclusively Broadcast Hero Nidahas Trophy 2018

Del

Cricket aficionados can catch the fast-paced action and the nerve-wracking excitement of the upcoming tri-nation series, Hero Nidahas Trophy 2018, between Bangladesh, India and Sri Lanka on YuppTV, the world’s leading OTT brand for South Asian content. The T20 matches will be held in Colombo, between March 6th and March 18th. All the matches will be exclusively available on YuppTV in the USA, Canada, Middle East and North Africa, Australia, New Zealand, Malaysia, United Kingdom and Europe.

The tri-series tournament, played in celebration of Sri Lanka’s 70th year of independence, will open with India taking on Sri Lanka in the opening match. The tournament will follow a round robin format, with all three teams playing each other twice, and the top two teams progressing to the final on March 18th.

Mr. Uday Reddy, Founder & CEO, YuppTV, said, “Unlike other games, cricket has exemplary viewership across the globe, and T20 cricket has helped it gain more popularity than ever before. We are pleased to have exclusive rights for broadcasting the Hero Nidahas Trophy 2018 series in various geographies and look forward to offering our viewers the convenience of streaming the action-packed game, without missing a single moment of the same.”

Cricket fans can watch all the action LIVE from R.Premadasa Stadium in Colombo on www.yupptv.com or via the YuppTV app on their smart TVs, smart Blu-ray players, streaming media players, gaming consoles, smartphones, and tablets.

About YuppTV:

YuppTV is one of the world’s largest internet-based TV and On-demand service provider for South Asian content, offering more than 300+ TV channels, 5000+ Movies and 100+ TV Shows in 14 languages. YuppTV recently received funding from Emerald Media, a Pan-Asian platform established by leading global investment firm KKR for investing in the media and entertainment sector, wherein Emerald Media acquired a significant minority stake in the company for US$50mn. Emerald Media is led by industry veterans Rajesh Kamat and Paul Aiello, supported by an experienced team of investment and operating executives. YuppTV had earlier raised its Series A round of funding from Poarch Creek Indian Tribe of Alabama.

YuppTV has 25000 hours of entertainment content catalogued in its library, while nearly 2500 hours of new on-demand content is added to the YuppTV platform every day. YuppTV offers Live TV and Catch-Up TV technology. It also offers YuppFlix, a movie on demand streaming service for Expat Market and recently launched YuppTV Originals to bring forth unconventional story telling in collaboration with the top talent from the movie industry. YuppTV is currently ranked #1 Internet Pay TV platform for Indians living abroad. YuppTV is the most downloaded Indian SmartTV app and it also boasts of 14.5 million mobile downloads with 4.0 user rating.

Visit https://www.yupptv.com/cricket/hero-nidahas-trophy-2018-t20/live-stream for more information.

Contact information

YuppTV
Shivam Agarwal, +91 8826460464
shivam@yupptv.com

Om Business Wire

Business Wire
Business Wire
24 Martin Lane
EC4R 0DR London

+44 20 7626 1982http://www.businesswire.co.uk

(c) 2018 Business Wire, Inc., All rights reserved.

Business Wire, a Berkshire Hathaway company, is the global leader in multiplatform press release distribution.

Følg saker fra Business Wire

Registrer deg med din epostadresse under for å få de nyeste sakene fra Business Wire på epost fortløpende. Du kan melde deg av når som helst.

Siste saker fra Business Wire

Dole’s Joint Venture Recycling Company Celebrates 25 Years21.5.2018 11:00Pressemelding

Dole Food Company announced today that Recyplast S.A., an innovative plastic recycling company based in Costa Rica and with joint ownership including a subsidiary of Dole Fresh Fruit, recently surpassed 25 years in its mission to dramatically reduce and reuse agricultural waste. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20180521005160/en/ Raul Martinez (right), General Manager of Dole Standard Fruit de Costa Rica, receives a plaque from Jose Miguel Ramirez, General Manager of Recyplast, in recognition of the contribution of Dole's banana plantations in the correct handling, storage, and provision of field plastic waste. The plastic recycling facility pioneered the collection of field plastics after use in banana growing operations in Costa Rica. This reuse and recycling process includes reclamation of plastic bags that protect bananas from weather and insects, as well as the collection of plastic twine used to prop the ba

ViiV Healthcare Receives EU Marketing Authorisation for Juluca (dolutegravir/rilpivirine), the First 2-Drug Regimen, Once-Daily, Single-Pill for the Treatment of HIV21.5.2018 10:11Pressemelding

ViiV Healthcare, the global specialist HIV company, majority owned by GlaxoSmithKline, with Pfizer Inc. and Shionogi Limited as shareholders, today announced that the European Commission has granted marketing authorisation for Juluca (dolutegravir 50mg/rilpivirine 25mg) for the treatment of human immunodeficiency virus type 1 (HIV-1) infection in adults who are virologically suppressed (HIV-1 RNA <50 copies/mL) on a stable antiretroviral regimen for at least six months with no history of virological failure and no known or suspected resistance to any non-nucleoside reverse transcriptase inhibitor or integrase inhibitor.1 Juluca is a 2-drug regimen of dolutegravir (ViiV Healthcare), the most widely prescribed integrase inhibitor worldwide,2 and rilpivirine (Janssen Sciences Ireland UC, part of the Janssen Pharmaceutical Companies of Johnson & Johnson).1 Deborah Waterhouse, CEO ViiV Healthcare said, “The European Commission Decision for Juluca is very positive news for people living with

Janssen Announces European Commission Approval of JULUCA®▼ (dolutegravir/rilpivirine), the First Two-Drug Regimen, Once-Daily, Single-Pill for the Treatment of HIV-121.5.2018 10:06Pressemelding

The Janssen Pharmaceutical Companies of Johnson & Johnson today announced that the European Commission has granted marketing authorisation for JULUCA® (dolutegravir 50mg [ViiV Healthcare]/rilpivirine 25mg [Janssen Sciences Ireland UC]).1 ViiV Healthcare, as the marketing authorisation holder, will market dolutegravir/rilpivirine in all countries in the European Union and European Economic Area. Dolutegravir/rilpivirine is the first two-drug regimen, once-daily, single-pill for the treatment of human immunodeficiency virus type 1 (HIV-1) infection in adults who are virologically suppressed (HIV-1 RNA <50 c/mL) on a stable antiretroviral regimen for at least six months with no history of virological failure and no known or suspected resistance to any non-nucleoside reverse transcriptase inhibitor (NNRTI) or integrase inhibitor (INI).1 “The European Commission Decision for dolutegravir/rilpivirine marks a significant milestone in our 25-year commitment to make HIV history,” said Brian Woo

Chugai Presents Results of Two Pivotal Phase lll Studies for its Bispecific Antibody HEMLIBRA® at WFH 201821.5.2018 09:44Pressemelding

Chugai Pharmaceutical Co., Ltd. (TOKYO:4519) today announced that full results from HAVEN 3 study (NCT02847637) and HAVEN 4 study (NCT03020160) evaluating Chugai’s hemophilia A treatment HEMLIBRA® [generic name: emicizumab (genetical recombination)] are being presented at the World Federation of Hemophilia 2018 World Congress held in Glasgow, Scotland from May 20 to 24. HAVEN 3 study is conducted in people with hemophilia A without inhibitors, and HAVEN 4 study is conducted in people with hemophilia A with or without inhibitors. Results from both studies will be presented as late-breaking abstracts. “The results from HAVEN 3 study demonstrate that HEMLIBRA, which was created with Chugai’s proprietary antibody engineering technologies, can reduce the bleeding risk in people with hemophilia A without inhibitors. The intra-patient comparison in this study also shows a statistically significant reduction in bleeding by HEMLIBRA prophylaxis compared to factor VIII therapy, the current stand

STATS Unveils STATS GPS, the Most Advanced Technology for Athlete Monitoring21.5.2018 07:00Pressemelding

Today, STATS, the worldwide leader in sports data and intelligence, unveiled STATS GPS, an innovative system that uses a revolutionary 50-Hz sampling frequency to provide the most advanced real-time GPS technology available. STATS GPS allows teams to monitor player performance with customizable metrics like accelerations/decelerations, energy expenditure, count of zone entries, and time, distance and power thresholds. The innovative solution uses real 50-Hz sampling frequency and allows practitioners to monitor up to 100 players in real-time and post session with over 300 GPS, IMU and HR derived metrics. Embedded in the GPS vests are textile heart-rate sensors, making STATS GPS the most advanced technology on the market. “Teams and conditioning coaches need the latest technology to ensure players stay at peak health and fitness during long seasons,” said Ryan Paterson, Chief Global Officer at STATS. “With STATS GPS’ new 50-Hz technology, teams can instantly get performance information,

MATCHESFASHION.COM Has Another Strong Year of Growth Driven by International Expansion21.5.2018 06:00Pressemelding

MATCHESFASHION.COM, the global luxury-shopping destination for men and women, experienced another strong year of growth in 2017 with revenue up 44% year on year. EBITDA was up 34% driven by international growth. Technology has enabled the business to scale internationally, enhance the customer experience and power social innovation such as the launch of The Style Daily and The Style Social, delivering unique daily content to users. The success of the app last year led to more than half of online business being conducted via mobile. 2017 also saw the launch of two local-language websites in French and Korean and, in October, funds advised by Apax Partners acquired a majority stake in the company. Building on this momentum in 2018, MATCHESFASHION.COM increased their physical footprint; the Hong Kong office has tripled in size and in April they launched a state-of-the-art creative studio in East London. In the summer a new 500,000 square ft global distribution centre will open in London f